Literature DB >> 18985736

Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion.

Derya Sargin1, Imam Hassouna, Swetlana Sperling, Anna-Leena Sirén, Hannelore Ehrenreich.   

Abstract

A small experimental cryolesion to the right parietal cortex of juvenile mice causes late-onset global brain atrophy with memory impairments, reminiscent of cognitive decline, and progressive brain matter loss in schizophrenia. However, the cellular events underlying this global neurodegeneration are not understood. Here we show, based on comprehensive stereological analysis, that early unilateral lesion causes immediate and lasting bilateral increase in the number of microglia in cingulate cortex and hippocampus, consistent with a chronic low-grade inflammatory process. Whereas the total number of neurons and astrocytes in these brain regions remain unaltered, pointing to a non- gliotic neurodegeneration (as seen in schizophrenia), the subgroup of parvalbumin-positive inhibitory GABAergic interneurons is increased bilaterally in the hippocampus, as is the expression of the GABA-synthesizing enzyme GAD67. Moreover, unilateral parietal lesion causes a decrease in the expression of synapsin1, suggesting impairment of presynaptic functions/neuroplasticity. Reduced expression of the myelin protein cyclic nucleotide phosphodiesterase, reflecting a reduction of oligodendrocytes, may further contribute to the observed brain atrophy. Remarkably, early intervention with recombinant human erythropoietin (EPO), a hematopoietic growth factor with multifaceted neuroprotective properties (intraperitoneal injection of 5000 IU/kg body weight every other day for 3 weeks), prevented all these neurodegenerative changes. To conclude, unilateral parietal lesion of juvenile mice induces a non- gliotic neurodegenerative process, susceptible to early EPO treatment. Although the detailed mechanisms remain to be defined, these profound EPO effects open new ways for prophylaxis and therapy of neuropsychiatric diseases, e.g. schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18985736     DOI: 10.1002/glia.20797

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  14 in total

1.  Effects of erythropoietin in murine-induced pluripotent cell-derived panneural progenitor cells.

Authors:  Nils Offen; Johannes Flemming; Hares Kamawal; Ruhel Ahmad; Wanja Wolber; Christian Geis; Holm Zaehres; Hans R Schöler; Hannelore Ehrenreich; Albrecht M Müller; Anna-Leena Sirén
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

Review 2.  Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

Authors:  Kamilla W Miskowiak; Maj Vinberg; Catherine J Harmer; Hannelore Ehrenreich; Lars V Kessing
Journal:  Psychopharmacology (Berl)       Date:  2011-09-23       Impact factor: 4.530

3.  Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice.

Authors:  Nora Hagemeyer; Susann Boretius; Christoph Ott; Axel Von Streitberg; Henrike Welpinghus; Swetlana Sperling; Jens Frahm; Mikael Simons; Pietro Ghezzi; Hannelore Ehrenreich
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

4.  Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat.

Authors:  Li Zhang; Michael Chopp; Rui Lan Zhang; Lei Wang; Jing Zhang; Ying Wang; Yier Toh; Manoranjan Santra; Mei Lu; Zheng Gang Zhang
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

5.  Evaluating the relationship between memory functioning and cingulum bundles in acute mild traumatic brain injury using diffusion tensor imaging.

Authors:  Trevor C Wu; Elisabeth A Wilde; Erin D Bigler; Ragini Yallampalli; Stephen R McCauley; Maya Troyanskaya; Zili Chu; Xiaoqi Li; Gerri Hanten; Jill V Hunter; Harvey S Levin
Journal:  J Neurotrauma       Date:  2010-02       Impact factor: 5.269

Review 6.  Microglial activation and progressive brain changes in schizophrenia.

Authors:  L E Laskaris; M A Di Biase; I Everall; G Chana; A Christopoulos; E Skafidas; V L Cropley; C Pantelis
Journal:  Br J Pharmacol       Date:  2016-01-08       Impact factor: 8.739

7.  Erythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury.

Authors:  Michelle E Schober; Daniela F Requena; Benjamin Block; Lizeth J Davis; Christopher Rodesch; T Charles Casper; Sandra E Juul; Raymond P Kesner; Robert H Lane
Journal:  J Neurotrauma       Date:  2014-02-15       Impact factor: 5.269

8.  Focal brain trauma in the cryogenic lesion model in mice.

Authors:  Furat Raslan; Christiane Albert-Weißenberger; Ralf-Ingo Ernestus; Christoph Kleinschnitz; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2012-04-05

Review 9.  Microglial dysregulation in psychiatric disease.

Authors:  Luciana Romina Frick; Kyle Williams; Christopher Pittenger
Journal:  Clin Dev Immunol       Date:  2013-04-18

10.  Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.

Authors:  Christiane Albert-Weissenberger; Christian Stetter; Sven G Meuth; Kerstin Göbel; Michael Bader; Anna-Leena Sirén; Christoph Kleinschnitz
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-09       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.